EUVIMED · CrossrefZeitschrift
Biotechnology Law Report
ISSN 0730-031X · SAGE Publications
Neueste Artikel
Selected Developments in Biotechnology Law and the Biotechnology Industry
Exploring the New Trial Data Protection Regime in China
Lawsuits in Monoclonal Antibody Biosimilars as a Corporate Strategy to Safeguard Intellectual Property Rights and Prevent Market Competition
Gilead Tenofovir Cases: Can Marketing a Nondefective Drug Constitute Negligence?
Wyeth LLC v. AstraZeneca Pharms. LP
Bd. of Regents of Univ. of Texas Sys. v. Bos. Sci. Corp.
Gilead Tenofovir Cases
The U.S. Congress Considers Patent Eligibility Reform
Am. Hosp. Ass’n v. Kennedy
Teva Pharms. Int’l GmbH v. Lilly
REGENXBIO Inc. v. Sarepta Therapeutics, Inc.
Drafting a Pharmaceutical Composition Claim Covering Later-Developed Combination Drugs Without Losing the Disclosure Requirement Challenge: In re Entresto , 125 F.4th 1090 (Fed. Cir. 2025)
From the GRATK Treaty to Chinese Domestic Law: Adapting Patent Disclosure Rules to Protect Genetic Resources and Associated Traditional Knowledge
Selected Developments in Biotechnology Law and the Biotechnology Industry
Reshaping Biotechnology Governance: The NSCEB Report, Congressional Testimony, and the Path Forward
Vanda Pharms., Inc. v. United States Food & Drug Admin
Food & Drug Admin. v. R. J. Reynolds Vapor Co.
Guardant Health, Inc. v. Univ. of Washington
Functional Features in Antibody Claims: The UPC vs. the EPO
Selected Developments in Biotechnology Law and the Biotechnology Industry
Data Risks and Legal Regulation of Non-Invasive Brain–Computer Interfaces
Do Access and Benefit-Sharing Obligations Apply to Digital Sequence Information?
Alnylam Pharms., Inc. v. Moderna, Inc.
Duke Univ. v. Sandoz Inc.
Seagen Inc. v. Daiichi Sankyo Co.
Can Artificial Intelligence-Generated Inventions Be Protected by Patent Law?
Assessing Legal and Ethical Considerations for Processing Digital Medical Data in China: Framework, Issues, and Policy Recommendations
Selected Developments in Biotechnology Law and the Biotechnology Industry
State Universities Push the Limits of Eleventh Amendment Sovereign Immunity at the Federal Circuit
Reversal of the Marketing Authorizations for HPV Vaccines and Uncertainty Regarding Utilization in China
Jahrgänge
2026 · 432025 · 472024 · 412023 · 382022 · 382021 · 472020 · 572019 · 532018 · 512017 · 502016 · 392015 · 342014 · 352013 · 1362012 · 3112011 · 1992010 · 1012009 · 1212008 · 1072007 · 1182006 · 1132005 · 1292004 · 1082003 · 982002 · 892001 · 992000 · 1011999 · 2031998 · 2301997 · 2421996 · 2151995 · 2061994 · 2951993 · 1351992 · 1031991 · 821990 · 621989 · 991988 · 871987 · 84
EUVIMED